electroCore, Inc. ECOR
Set alert
7.52 USD -0.59 -7.27%
At close · Oct 30
7.53 +0.01 +0.12%
After hours · Oct 30, 7:43 PM ET
7.50 Day range 8.54
4.42 52-week range 12.29
- YTD
- +67.48%
- 1 year
- +54.10%
- Open
- 7.76
- Prev close
- 8.11
- Mkt cap
- 67.80M
- Vol
- 65.78K
- Avg vol
- 87.68K
- EPS
- -1.65
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 7.50
- High
- 8.54
- Forward P/E
- -31.85
- Beta
- 0.56
- Short ratio
- 0.54
- Inst. own
- 16.11%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 11.57
- 200-d avg
- 7.64
- 1y target
- 25.47
Key statistics
- Market cap
- 114.84M
- Enterprise value
- 77.42M
- Trailing P/E
- 0.00
- Forward P/E
- -31.85
- PEG ratio
- 0.00
- Price / sales
- 5.40
- Price / book
- 14.13
- EPS (TTM)
- -1.74
- Beta
- 0.56
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -66.84%
- Revenue (TTM)
- 21.28M
- Revenue growth
- 72.90%
- Free cash flow
- -6.56M
- Total cash
- 14.23M
- Total debt
- 3.97M
- Return on equity
- -153.49%
- Shares outstanding
- 6.55M
- Short % of float
- 1.04%
- 50-day average
- 11.57
- 200-day average
- 7.64
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 25.47 +238.7% upside
Now 7.52
- Target (low)
- 20.00
- Target (mean)
- 25.47
- Target (high)
- 29.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy2
- Buy3
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 7, 2024
Expected Aug 7, 2024. Consensus EPS estimate 0.00.
Financials — quick view
ECOR Revenue — quarterly 9.45M
ECOR Net income — quarterly -3.06M
ECOR EPS — quarterly -0.33
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | -0.29 | -0.31 | -0.02 | -6.90% |
| Aug 7, 2024 | Jun 1, 2024 | -0.39 | -0.38 | +0.01 | +2.56% |
| Aug 7, 2024 | Jun 1, 2024 | -0.39 | — | — | — |
| May 8, 2024 | Mar 1, 2024 | -0.50 | -0.53 | -0.03 | -6.00% |
| May 8, 2024 | Mar 1, 2024 | -0.50 | — | — | — |
| Mar 13, 2024 | Dec 1, 2023 | -0.55 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 18, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Mar 14, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Jan 22, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Nov 9, 2023 | HC Wainwright & Co. | main | Buy | Buy |
| Aug 10, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| May 4, 2023 | HC Wainwright & Co. | main | — | Buy |
About electroCore, Inc.
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- electrocore.com
News
- electroCore to Announce Third Quarter September 30, 2026, Financial Results on Wednesday, November 4, 2026
- electroCore Targets 2027 EBITDA Profit as VA, Quell and CIPN Opportunities Expand
- electroCore Submits Premarket Notification Seeking Clearance From FDA For Its Quell Wearable Neuromodulation Platform To Treat Chronic Chemotherapy-Induced Peripheral Neuropathy
- electroCore, Inc. Submits 510(k) Premarket Notification to FDA Seeking Clearance of Quell® for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)
- electroCore (NASDAQ:ECOR) Share Price Crosses Above 200-Day Moving Average – Here’s What Happened
- fMRI Study Suggests Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) Accelerates Neural Processes in Visual Skill Learning
- Full Transcript: electroCore Q2 2026 Earnings Call
- electroCore Appoints Joshua Lev, Mike Fox As Co-CEOs, Effective Sept. 8
- electroCore Lowers FY2026 Sales Guidance from $41.642M to $41.600M vs $41.921M Est
- electroCore Q2 EPS $(0.33) Beats $(0.40) Estimate, Sales $9.450M Miss $9.491M Estimate
Your note
Sign in to keep a note on ECOR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CUNEO F. PETER | Director | Stock Award(Grant) | Aug 1, 2023 | 5,665 |
| ERRICO THOMAS J. | Director | Stock Award(Grant) | Sep 2, 2024 | 250,401 |
| GANDOLFO JOHN P | Director | Stock Award(Grant) | Sep 2, 2024 | 67,287 |
| GOLDBERGER DANIEL S | Chief Executive Officer | Purchase | Jun 4, 2024 | 249,565 |
| GOLDSTEIN JULIE ANN | Director | Stock Award(Grant) | Jun 4, 2024 | 77,380 |
| MOODY TREVOR J. | Director | Stock Award(Grant) | Aug 1, 2023 | 67,592 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| AWM Investment Company, Inc. | 7.78% | 510,094 | 8.94M | Sep 29, 2024 |
| Vanguard Group Inc | 2.58% | 168,924 | 2.96M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 1.11% | 72,986 | 1.28M | Sep 29, 2024 |
| International Assets Investment Management, LLC | 1.03% | 67,820 | 1.19M | Jun 29, 2024 |
| Geode Capital Management, LLC | 0.97% | 63,485 | 1.11M | Sep 29, 2024 |
| Wealthspire Advisors, LLC | 0.72% | 47,498 | 832.16K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.57% | 102,775 | 1.80M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.88% | 57,506 | 1.01M | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.44% | 28,853 | 505.50K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.19% | 12,456 | 218.23K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.18% | 11,711 | 205.18K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.17% | 10,983 | 192.42K | Oct 30, 2024 |